Oculex Pharmaceuticals
Sunnyvale, California, United States
About Oculex Pharmaceuticals
Oculex Pharmaceuticals is an ophthalmic drug delivery company that is focused on the development of therapeutic products for the treatment of sight-threatening diseases. Oculex Pharmaceuticals develops Posurdex, a biodegradable release implant that delivers dexamethasone to the targeted disease site at the back of the eye. Oculex Pharmaceuticals was acquired by Allergan in November 2003. Oculex Pharmaceuticals was founded in 1989 and is based in Sunnyvale, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $50.0M
- Funding stage: M&A
- Last round: Series B (Oct 2002)
- Website: oculex.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/oculex-pharmaceuticals-2570222 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.